The aortic endografts market was valued at $3.3 billion in 2024 and is estimated to reach $6.2 billion by 2034, exhibiting a CAGR of 6.3% from 2025 to 2034. Aortic endografts are specialized medical devices used in aneurysm repair procedures to treat aortic aneurysms abnormal bulges in the wall of the aorta. Aortic aneurysm repair refers to the medical procedures and interventions aimed at treating and managing abnormalities in the aorta, the body's main artery.
An aortic aneurysm is characterized by abnormal bulging or dilation of the aorta's walls, which can pose a serious health risk if left untreated. Aortic endografts are minimally invasive implants that consist of a fabric-covered metallic stent, which is inserted into the aorta via a catheter to reinforce the weakened section of the artery and prevent rupture. Aortic endografts are typically thoracic, and abdominal, which may be complex, fenestrated, or branched types.
The major factors driving the aortic endograft market are the increasing global burden of aortic aneurysms, particularly among the aging population. Lifestyle related conditions such as hypertension, smoking, and atherosclerosis further contribute to the incidence of aneurysms. However, despite their clinical benefits, aortic endografts remain expensive, both in terms of device cost and procedural requirements. Limited reimbursement in some regions and the need for specialized equipment and expertise can restrict widespread adoption, particularly in low and middle income countries.
Moreover, by offering financial support or insurance coverage, governments encourage healthcare providers and patients to opt for aortic aneurysm repair, thus driving the market growth. These reimbursement policies reduce the financial burden on patients and improve access to advanced treatment options. Manufacturers of aortic aneurysm repair devices are increasingly partnering with insurance companies to streamline the reimbursement process and ensure coverage for their products.
In addition, technological advancements, continuous innovation in device design such as branched and fenestrated grafts have expanded the applicability of aortic endografts to more complex anatomies. Companies are investing in next-generation graft materials, enhanced sealing mechanisms, and better delivery systems. Fenestrated, branched & hybrid endografts have matured, enabling treatment of increasingly complex anatomies such as short-necked or angled aneurysms by providing improved anatomical fit and expanded clinical indications.
In addition, new graft materials including more biocompatible, durable polymers and metallic frameworks, are reducing long-term complications like migration, endoleaks, and graft failure. These advancements are improving procedural success rates and expanding the market scope to previously inoperable or high-risk cases.
The aortic endograft market is segmented into type, procedure, end user, and region. By type, the market is categorized into abdominal aortic endografts and thoracic aortic endografts. On the basis of procedure, it is segregated into open surgery, endovascular aortic aneurysm repair, and frozen elephant trunk. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia, and LAMEA.
Major key players that operate in the global aortic endograft market are Medtronic plc, Artivion, Inc, Terumo Corporation, W. L. Gore and Associates, Inc., MicroPort Scientific Corporation, Cook Group Inc., ENDOLOGIX LLC, Cordis Corporation, Bentley InnoMed GmbH, and Braile Biomédica S.A.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the aortic endografts market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global aortic endografts market trends, key players, market segments, application areas, and market growth strategies.
An aortic aneurysm is characterized by abnormal bulging or dilation of the aorta's walls, which can pose a serious health risk if left untreated. Aortic endografts are minimally invasive implants that consist of a fabric-covered metallic stent, which is inserted into the aorta via a catheter to reinforce the weakened section of the artery and prevent rupture. Aortic endografts are typically thoracic, and abdominal, which may be complex, fenestrated, or branched types.
The major factors driving the aortic endograft market are the increasing global burden of aortic aneurysms, particularly among the aging population. Lifestyle related conditions such as hypertension, smoking, and atherosclerosis further contribute to the incidence of aneurysms. However, despite their clinical benefits, aortic endografts remain expensive, both in terms of device cost and procedural requirements. Limited reimbursement in some regions and the need for specialized equipment and expertise can restrict widespread adoption, particularly in low and middle income countries.
Moreover, by offering financial support or insurance coverage, governments encourage healthcare providers and patients to opt for aortic aneurysm repair, thus driving the market growth. These reimbursement policies reduce the financial burden on patients and improve access to advanced treatment options. Manufacturers of aortic aneurysm repair devices are increasingly partnering with insurance companies to streamline the reimbursement process and ensure coverage for their products.
In addition, technological advancements, continuous innovation in device design such as branched and fenestrated grafts have expanded the applicability of aortic endografts to more complex anatomies. Companies are investing in next-generation graft materials, enhanced sealing mechanisms, and better delivery systems. Fenestrated, branched & hybrid endografts have matured, enabling treatment of increasingly complex anatomies such as short-necked or angled aneurysms by providing improved anatomical fit and expanded clinical indications.
In addition, new graft materials including more biocompatible, durable polymers and metallic frameworks, are reducing long-term complications like migration, endoleaks, and graft failure. These advancements are improving procedural success rates and expanding the market scope to previously inoperable or high-risk cases.
The aortic endograft market is segmented into type, procedure, end user, and region. By type, the market is categorized into abdominal aortic endografts and thoracic aortic endografts. On the basis of procedure, it is segregated into open surgery, endovascular aortic aneurysm repair, and frozen elephant trunk. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia, and LAMEA.
Major key players that operate in the global aortic endograft market are Medtronic plc, Artivion, Inc, Terumo Corporation, W. L. Gore and Associates, Inc., MicroPort Scientific Corporation, Cook Group Inc., ENDOLOGIX LLC, Cordis Corporation, Bentley InnoMed GmbH, and Braile Biomédica S.A.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the aortic endografts market analysis from 2024 to 2034 to identify the prevailing aortic endografts market opportunities.The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the aortic endografts market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global aortic endografts market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly update with the purchase of an enterprise license.
- 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
- Free version update with the purchase of an Enterprise User License.
- 16 hours of analyst support.
- 15% free customization (Equivalent to 3 working days of work, applicable once).
- Free data pack (Excel) with the purchase of an Enterprise User License.
- Free updated report if the report is 6-12 months old or older.
- 24-hour priority response.
- Free industry updates and white papers.
Further possible customization (additional cost and timeline):
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis - market size and forecast
- Expanded list for Company Profiles
- Reimbursement Scenario
- SWOT Analysis
Key Market Segments
By Type
- Abdominal Aortic Endografts
- Thoracic Aortic Endografts
By Procedure
- Frozen Elephant Trunk
- Open Surgical Repair
- Endovascular Aneurysm Repair
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- W. L. Gore & Associates, Inc.
- Terumo Corporation
- Cook Group
- Endologix Inc.
- Braile Biomédica S.A.
- Bentley InnoMed GmbH
- Artivion, Inc.
- MicroPort Scientific Corporation
- Cordis Corporation
- Medtronic plc
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: AORTIC ENDOGRAFTS MARKET, BY TYPE
CHAPTER 5: AORTIC ENDOGRAFTS MARKET, BY PROCEDURE
CHAPTER 6: AORTIC ENDOGRAFTS MARKET, BY END USER
CHAPTER 7: AORTIC ENDOGRAFTS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- W. L. Gore & Associates, Inc.
- Terumo Corporation
- Cook Group
- Endologix Inc.
- Braile Biomédica S.A.
- Bentley InnoMed GmbH
- Artivion, Inc.
- MicroPort Scientific Corporation
- Cordis Corporation
- Medtronic plc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
